About Lipur Pharmaceuticals
Lipur Pharmaceuticals is a Healthcare company. Distribution of generic drugs and healthcare products in India. Its Indian entity Lipur Pharmaceuticals Private Limited reported revenue of ₹3.34 Cr. Lipur Pharmaceuticals offers products and services including Arnilow 50 and Amoxlip 625. Its focus areas include Medical Supplies, Healthcare Devices, Supplements and Products and Pharmaceuticals.
Company details
Lipur Pharmaceuticals is recognized as a distributor of generic drugs in India, where cost-effective medicines are provided to customers while balancing quality and feasibility. World-class standards in manufacturing and quality control are adhered to, and authentic medicines are dispensed following legal guidelines. Discounts on prescribed items and healthcare devices are made available, with operations supported by over 12 years of experience and more than 50 products. The company is headquartered in Patna, facilitating access with an intuitive interface.
- SectorsHealthcare
- Website lipurpharma.com
- Legal Name Lipur Pharmaceuticals Private Limited
- Date of Incorporation 03 Mar, 2017
- Jurisdiction Patna, Bihar, India
- Indian entity revenue₹3.34 Cr
FY 2024 · +33% YoY
- Indian entity net profit₹2.9 Lakh
FY 2024 · 1% margin
- Indian entity EBITDA₹3.8 Lakh
FY 2024 · 1% margin
Associated legal entities of Lipur Pharmaceuticals
Lipur Pharmaceuticals operates through Lipur Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Lipur Pharmaceuticals Private Limited CIN U74999BR2017PTC033873 | Active | 03 Mar 2017 | Patna, Bihar | ₹3.3 Cr | 4 | 2 | View details |
Products & Services of Lipur Pharmaceuticals
Lipur Pharmaceuticals offers a comprehensive portfolio of products and services, including Arnilow 50 and Amoxlip 625.
Arnilow 50 is distributed as a generic drug for medical use, with quality controlled according to established standards.
Amoxlip 625 is offered as another generic drug, adhering to manufacturing guidelines for healthcare purposes.
Board of directors of Lipur Pharmaceuticals Private Limited (Lipur Pharmaceuticals)
Lipur Pharmaceuticals Private Limited is the primary company behind Lipur Pharmaceuticals. The board of Lipur Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Ritika, appointed in 2017. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ritika DIN 07685749 | Director | 03 Mar 2017 | 9 yrs 8 mo | Lipur Pharmaceuticals Private Limited |
| Kavita Jha DIN 10341962 | Additional Director | 08 Nov 2023 | 2 yrs 11 mo | Lipur Pharmaceuticals Private Limited |
Financials of Lipur Pharmaceuticals
Figures of Lipur Pharmaceuticals Private Limited, the primary company behind Lipur Pharmaceuticals, for FY 2024. Revenue was ₹3.34 Cr (+33% year on year). Net profit was ₹2.9 Lakh (1% margin). EBITDA was ₹3.8 Lakh (1% margin). Revenue has grown at a compounded annual rate of +30% over three years and +70% over five years.
- ₹3.34 CrRevenue · FY 2024 · +33% YoY
- ₹2.9 LakhNet profit · 1% margin
- ₹3.8 LakhEBITDA · 1% margin
- ₹95 LakhPaid-up capital
- 4Employees (provident fund records)
- +30%Revenue CAGR, 3 years
- +70%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Lipur Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Lipur Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lipur Pharmaceuticals
The primary company behind Lipur Pharmaceuticals, Lipur Pharmaceuticals Private Limited, reported revenue of ₹3.34 Cr for FY 2024, up 33% year on year.
Lipur Pharmaceuticals is recognized as a distributor of generic drugs in India, where cost-effective medicines are provided to customers while balancing quality and feasibility. World-class standards in manufacturing and quality control are adhered to, and authentic medicines are dispensed following legal guidelines. Discounts on prescribed items and healthcare devices are made available, with operations supported by over 12 years of experience and more than 50 products. The company is headquartered in Patna, facilitating access with an intuitive interface.
Lipur Pharmaceuticals offers Arnilow 50 and Amoxlip 625.
Lipur Pharmaceuticals operates through Lipur Pharmaceuticals Private Limited.
The legal entities of Lipur Pharmaceuticals currently have 2 directors, including Kavita Jha, Ritika.